Zierer Andreas, De Paulis Ruggero, Bakhtiary Farhad, Ahmad Ali El-Sayed, Andreas Martin, Autschbach Rüdiger, Benedikt Peter, Binder Konrad, Bonaros Nikolaos, Borger Michael, Bourguignon Thierry, Canovas Sergio, Coscioni Enrico, Dagenais Francois, Demers Philippe, Dewald Oliver, Feyrer Richard, Geißler Hans-Joachim, Grabenwöger Martin, Grünenfelder Jürg, Kueri Sami, Lam Ka Yan, Langanay Thierry, Laufer Günther, Van Leeuwen Wouter, Leyh Rainer, Liebold Andreas, Mariscalco Giovanni, Massoudy Parwis, Mehdiani Arash, Pessotto Renzo, Pollari Francesco, Polvani Gianluca, Ricci Alessandro, Roussel Jean-Christian, Salamate Saad, Siepe Matthias, Stefano Pierluigi, Strauch Justus, Theron Alexis, Vötsch Andreas, Weber Alberto, Wendler Olaf, Thielmann Matthias, Eden Matthias, Botta Beate, Bramlage Peter, Meuris Bart
Department of Cardiac, Vascular and Thoracic Surgery, Kepler University Hospital Linz, Linz, Austria.
Department of Cardiac, Vascular and Thoracic Surgery, Hospital Wels-Grieskirchen, Wels, Austria.
Interdiscip Cardiovasc Thorac Surg. 2024 Aug 1;39(2). doi: 10.1093/icvts/ivae140.
We investigated the sex-related difference in characteristics and 2-year outcomes after surgical aortic valve replacement (SAVR) by propensity-score matching (PSM).
Data from 2 prospective registries, the INSPIRIS RESILIA Durability Registry (INDURE) and IMPACT, were merged, resulting in a total of 933 patients: 735 males and 253 females undergoing first-time SAVR. The PSM was performed to assess the impact of sex on the SAVR outcomes, yielding 433 males and 243 females with comparable baseline characteristics.
Females had a lower body mass index (median 27.1 vs 28.0 kg/m2; P = 0.008), fewer bicuspid valves (52% vs 59%; P = 0.036), higher EuroSCORE II (mean 2.3 vs 1.8%; P < 0.001) and Society of Thoracic Surgeons score (mean 1.6 vs 0.9%; P < 0.001), were more often in New York Heart Association functional class III/IV (47% vs 30%; P < 0.001) and angina Canadian Cardiovascular Society III/IV (8.2% vs 4.4%; P < 0.001), but had a lower rate of myocardial infarction (1.9% vs 5.2%; P = 0.028) compared to males. These differences vanished after PSM, except for the EuroSCORE II and Society of Thoracic Surgeons scores, which were still significantly higher in females. Furthermore, females required smaller valves (median diameter 23.0 vs 25.0 mm, P < 0.001). There were no differences in the length of hospital stay (median 8 days) or intensive care unit stay (median 24 vs 25 hours) between the 2 sexes. At 2 years, post-SAVR outcomes were comparable between males and females, even after PSM.
Despite females presenting with a significantly higher surgical risk profile, 2-year outcomes following SAVR were comparable between males and females.
我们通过倾向评分匹配(PSM)研究了外科主动脉瓣置换术(SAVR)后特征及2年预后的性别差异。
将来自两个前瞻性注册研究(INSPIRIS RESILIA耐久性注册研究(INDURE)和IMPACT)的数据合并,共有933例患者:735例男性和253例女性接受首次SAVR。进行PSM以评估性别对SAVR预后的影响,得到433例男性和243例女性,其基线特征具有可比性。
女性的体重指数较低(中位数27.1 vs 28.0kg/m²;P = 0.008),二叶式瓣膜较少(52% vs 59%;P = 0.036),欧洲心脏手术风险评估系统II(EuroSCORE II)较高(平均值2.3 vs 1.8%;P < 0.001)和胸外科医师协会评分较高(平均值1.6 vs 0.9%;P < 0.001),纽约心脏协会心功能分级III/IV级的比例更高(47% vs 30%;P < 0.001)以及加拿大心血管学会心绞痛分级III/IV级的比例更高(8.2% vs 4.4%;P < 0.001),但与男性相比,心肌梗死发生率较低(1.9% vs 5.2%;P = 0.028)。PSM后这些差异消失,但EuroSCORE II和胸外科医师协会评分除外,女性的这些评分仍显著更高。此外,女性需要尺寸更小的瓣膜(中位数直径23.0 vs 25.0mm,P < 0.001)。两性之间住院时间(中位数8天)或重症监护病房停留时间(中位数24 vs 25小时)没有差异。在2年时,即使在PSM后,SAVR术后男性和女性的预后仍具有可比性。
尽管女性的手术风险显著更高,但SAVR术后2年男性和女性的预后具有可比性。